Tower Research Capital (TRC)’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67.2K | Buy |
19,760
+15,250
| +338% | +$51.9K | ﹤0.01% | 2719 |
|
|
2025
Q1 | $18.1K | Buy |
4,510
+1,421
| +46% | +$5.7K | ﹤0.01% | 3064 |
|
|
2024
Q4 | $20K | Buy |
3,089
+687
| +29% | +$4.46K | ﹤0.01% | 3180 |
|
|
2024
Q3 | $13.3K | Sell |
2,402
-14,652
| -86% | -$81.2K | ﹤0.01% | 3526 |
|
|
2024
Q2 | $95.2K | Buy |
17,054
+15,658
| +1,122% | +$87.4K | ﹤0.01% | 2621 |
|
|
2024
Q1 | $9.37K | Sell |
1,396
-34,890
| -96% | -$234K | ﹤0.01% | 3856 |
|
|
2023
Q4 | $331K | Buy |
36,286
+30,475
| +524% | +$278K | ﹤0.01% | 1701 |
|
|
2023
Q3 | $32.1K | Buy |
5,811
+2,362
| +68% | +$13K | ﹤0.01% | 2967 |
|
|
2023
Q2 | $29.5K | Sell |
3,449
-8,373
| -71% | -$71.5K | ﹤0.01% | 3011 |
|
|
2023
Q1 | $109K | Sell |
11,822
-504
| -4% | -$4.65K | ﹤0.01% | 1789 |
|
|
2022
Q4 | $125K | Buy |
12,326
+4,082
| +50% | +$41.4K | 0.01% | 1650 |
|
|
2022
Q3 | $121K | Buy |
8,244
+4,393
| +114% | +$64.5K | ﹤0.01% | 2401 |
|
|
2022
Q2 | $41K | Buy |
3,851
+1,966
| +104% | +$20.9K | ﹤0.01% | 3077 |
|
|
2022
Q1 | $20K | Buy |
1,885
+436
| +30% | +$4.63K | ﹤0.01% | 3524 |
|
|
2021
Q4 | $23K | Buy |
1,449
+940
| +185% | +$14.9K | ﹤0.01% | 3501 |
|
|
2021
Q3 | $11K | Buy |
+509
| New | +$11K | ﹤0.01% | 4213 |
|